Peds I (Pediatric Eplerenone Development Study I): a randomized, double-blind, placebo withdrawal, parallel group, dose-response study to evaluate the efficacy and safety of eplerenone in the treatment of hypertension in children

Trial Profile

Peds I (Pediatric Eplerenone Development Study I): a randomized, double-blind, placebo withdrawal, parallel group, dose-response study to evaluate the efficacy and safety of eplerenone in the treatment of hypertension in children

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Apr 2010

At a glance

  • Drugs Eplerenone (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Acronyms PEDS-I
  • Most Recent Events

    • 16 Apr 2010 Results published in Journal of Pediatrics.
    • 30 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top